Nevada 2025 Regular Session

Nevada Senate Bill SB168

Refer
2/3/25  
Introduced
2/5/25  
Report Pass
4/21/25  
Engrossed
4/28/25  
Refer
4/28/25  
Report Pass
5/20/25  
Enrolled
5/29/25  
Chaptered
6/6/25  

Caption

Revises provisions relating to cannabis. (BDR 56-553)

Summary

SB168 revises Nevada’s cannabis laws in several operational areas. It updates definitions, including “usable cannabis,” to exclude cannabis seeds, and expands the authority of adult-use and medical cannabis production facilities to acquire, possess, package, supply, and sell usable cannabis to retail stores and dispensaries. The bill also authorizes cannabis cultivation and production facilities to sell cannabis seeds, branded merchandise, and related supplies both inside and outside Nevada, subject to state and local law restrictions for out-of-state transactions. The bill makes a series of regulatory and packaging changes. It limits the Cannabis Compliance Board’s ability to issue hold orders to circumstances set by regulation, requires notice, hearing, and automatic termination after 30 days unless extended for good cause, and directs the Board to adopt regulations and publish guidelines on hold orders. It also changes packaging and labeling rules so wholesale packages do not need redundant labels, allows required label information to appear on packaging instead, and requires the Board to create standardized approval checklists and post an FAQ page for licensees. For consumer sales, the bill revises single-package limits for cannabis and THC, raises several THC caps, and adds a 7-gram maximum for infused pre-rolls. SB168 also affects advertising and consumer safety rules. It preserves and clarifies restrictions on child-appealing marketing, requires certain warnings and identifying information in advertising, and allows local governments to adopt more restrictive advertising ordinances in specified areas. The bill continues to require child-resistant, opaque packaging and consumer warnings at point of sale, while also allowing some required label text to be placed on packaging instead of a separate label. It becomes effective upon passage and approval. The overall sentiment around the bill appears strongly favorable and noncontroversial in the Legislature. It passed the Senate unanimously, 20-0, and the Assembly unanimously, 42-0, indicating broad bipartisan support. The lack of recorded committee transcript debate also suggests the measure was viewed as a technical or administrative update rather than a contentious policy shift. The main points of contention, to the extent they can be inferred from the bill text, are regulatory burden and market flexibility. The bill reduces some packaging and labeling redundancy for licensees while tightening Board procedures for hold orders, which may appeal to industry stakeholders seeking clearer and more predictable rules. At the same time, it preserves strong consumer-protection and youth-access restrictions, so any tension would likely be between cannabis businesses seeking operational flexibility and regulators or public-health advocates focused on oversight, labeling clarity, and child safety.

Impact

SB168 amends multiple provisions in NRS Chapters 678A, 678B, 678C, and 678D governing Nevada’s medical and adult-use cannabis systems. It changes statutory definitions, expands what production and cultivation facilities may handle and sell, narrows and standardizes the Cannabis Compliance Board’s hold-order authority, and revises packaging, labeling, advertising, and package-content limits. It also repeals two existing provisions and makes conforming changes across the cannabis code, affecting licensees, the Board, consumers, and local governments that regulate cannabis advertising.

Sentiment

The bill’s legislative reception was overwhelmingly positive. It passed both chambers unanimously, with 20-0 in the Senate and 42-0 in the Assembly, suggesting broad agreement that the measure is a practical update to cannabis regulation. The available record does not show significant opposition or divided committee debate.

Contention

The most notable issues are administrative control versus industry flexibility. The bill gives the Cannabis Compliance Board clearer procedures for hold orders and requires standardized checklists and FAQs, which may be seen as improving predictability, but it also constrains the Board’s discretion by limiting hold orders to defined circumstances and requiring notice, hearings, and automatic expiration. Another area of potential tension is packaging and labeling: the bill reduces redundant labeling requirements and allows more information to appear on packaging, which benefits businesses, while maintaining strict consumer-warning and child-safety rules. Advertising restrictions remain robust, and local governments retain authority to impose stricter rules, so the balance between commercial freedom and public-health protections is a central theme.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.